Case study

Addressing an Evidentiary Gap With Real-World Prospective Studies

Learn how Xcenda helped one client address an evidence gap for a revolutionary new orphan drug.

Related resources

Article

AI-powered tools for pricing: Key takeaways from ISPOR Europe 2025

Article

Rethinking oncology launches: How the next generation of patients is reshaping strategies

Newsletter

HTA Quarterly Spring 2026